基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
Purpose: To study the safety and efficacy of 1/3-dose verteporfin photodynamic therapy (PDT) for subacute central serous chorioretinopathy (CSC). Methods: In this case series, 59 eyes (59 patients) diagnosed with subacute CSC in Shenyang the 4th hospital from January 2014 to December 2015 were treated with 1/3-dose verteporfin PDT and followed up for at least 1 year. The symptoms and the diagnosed history were more than 3 months but shorter than 6 months. The central foveal thickness (CFT), neuroretinal thickness (NRT), height of subfoveal retinal fluid (SRF), and subfoveal choroidal thickness (SCT) were observed at baseline and after treated at 1, 2, 3, 6 and 12 months with EDI-OCT, Best-corrected visual acuity ( BCVA) was also studied at the same time. Results: After 1, 2, 3 and 6 months of 1/3-dose verteporfin PDT treatment, the BCVA improved significantly (P 0.05). The height of SRF changed significantly. There was no retinal pigment epithelium atrophy and choroidal neovascularization (CNV) in all cases after more than 12 months follow-up. Conclusion: Treatment of 1/3 dose verteporfin PDT could safely and effectively reduce expansion of choroidal vessel and choroidal choriocapillary, promoting absorbance of subretinal fluid for subacute CSC. 1/3-dose verteporfin PDT may be an alternative method to treat the subacute CSC.
推荐文章
半量维替泊芬光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变
慢性中心性浆液性脉络膜视网膜病变
光动力疗法
半量维替泊芬
应用1/3剂量光动力学疗法治疗急性CSC
急性中心性浆液性视网膜脉络膜病变
1/3剂量光动力疗法
Priming Therapy方案治疗难治复发性急性髓性白血病的临床研究
急性髓细胞白血病
粒细胞集落刺激因子
阿糖胞苷
阿克拉霉素
高三尖杉酯碱化疗
凋亡
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 Efficacy of 1/3-Dose Verteporfin Photodynamic Therapy for Subacute Central Serous Chorioretinopathy
来源期刊 眼科学期刊(英文) 学科 医学
关键词 SUBACUTE CENTRAL Serous CHORIORETINOPATHY (CSC) 1/3-Dose VERTEPORFIN Photodynamic Therapy (PDT) Subfoveal Choroidal Thickness (SCT) Neuroretinal Thickness (NRT) CENTRAL Foveal Thickness (CFT)
年,卷(期) 2017,(4) 所属期刊栏目
研究方向 页码范围 310-318
页数 9页 分类号 R73
字数 语种
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (0)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2017(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
研究主题发展历程
节点文献
SUBACUTE
CENTRAL
Serous
CHORIORETINOPATHY
(CSC)
1/3-Dose
VERTEPORFIN
Photodynamic
Therapy
(PDT)
Subfoveal
Choroidal
Thickness
(SCT)
Neuroretinal
Thickness
(NRT)
CENTRAL
Foveal
Thickness
(CFT)
研究起点
研究来源
研究分支
研究去脉
引文网络交叉学科
相关学者/机构
期刊影响力
眼科学期刊(英文)
季刊
2165-7408
武汉市江夏区汤逊湖北路38号光谷总部空间
出版文献量(篇)
241
总下载数(次)
0
总被引数(次)
0
论文1v1指导